Growth Metrics

Insulet (PODD) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.39%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.38%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 6.53%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 56.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 56.43%
Dec 31, 2025 81.47%
Sep 30, 2025 166.12%
Jun 30, 2025 38.26%
Mar 31, 2025 8.39%
Dec 31, 2024 51.08%
Sep 30, 2024 83.22%
Jun 30, 2024 112.12%
Dec 31, 2023 100.34%
Sep 30, 2023 64.78%
Jun 30, 2023 23.77%
Mar 31, 2023 137.13%
Dec 31, 2022 50.37%
Sep 30, 2022 -104.08%
Jun 30, 2022 -200.00%
Mar 31, 2022 84.87%
Dec 31, 2021 43.41%
Sep 30, 2021 94.97%
Jun 30, 2021 -145.00%
Dec 31, 2020 -35.59%
Sep 30, 2020 93.18%
Jun 30, 2020 56.78%
Mar 31, 2020 40.52%
Dec 31, 2019 36.55%
Sep 30, 2019 31.22%
Jun 30, 2019 32.42%
Mar 31, 2019 34.10%
Dec 31, 2018 37.90%
Sep 30, 2018 27.85%
Jun 30, 2018 53.82%
Mar 31, 2018 17.69%
Dec 31, 2017 -8.30%
Sep 30, 2017 41.00%
Jun 30, 2017 35.62%
Mar 31, 2017 -17.54%
Dec 31, 2016 -54.13%
Sep 30, 2016 47.50%
Jun 30, 2016 25.49%
Mar 31, 2016 -0.07%
Dec 31, 2015 -15.99%
Sep 30, 2015 -15.09%
Jun 30, 2015 -6.05%
Mar 31, 2015 7.14%
Dec 31, 2014 27.78%
Sep 30, 2014 7.18%
Jun 30, 2014 -53.28%
Mar 31, 2014 14.55%
Dec 31, 2013 50.70%
Sep 30, 2013 -20.72%
Jun 30, 2013 8.45%